GlassScriptPhysician profile
Son Phong Le
NPI 1902988009
$2,851.56
in general payments reported to CMS, 2019-2025
16 companies · $1,787 in 2025
The $1,787 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $96.16 · 2021: $183 · 2022: $571 · 2023: $50.74 · 2024: $18.93 · 2025: $1,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,391 · Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,391.15 |
| Food and Beverage | $465.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,818.01 | 2022-2025 | Micra, In.Pact Admiral |
| Abiomed | $326.81 | 2020-2022 | |
| Biotronik INC. | $159.28 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $108.37 | 2019-2022 | |
| Penumbra, INC. | $101.00 | 2022 | |
| Abbott Laboratories | $82.53 | 2019-2021 | |
| Pfizer INC. | $56.13 | 2019-2023 | |
| W. L. Gore & Associates, INC. | $44.01 | 2022 | |
| Chiesi USA, INC. | $33.96 | 2022-2023 | Kengreal |
| Boston Scientific Corporation | $25.25 | 2019-2022 | |
| Cardiovascular Systems INC. | $23.55 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $18.93 | 2024 | Amvuttra |
| Inari Medical, INC. | $17.75 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.79 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $12.25 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Son Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.